Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
11.07
+0.44 (4.14%)
At close: Sep 17, 2025, 4:00 PM EDT
11.19
+0.12 (1.08%)
After-hours: Sep 17, 2025, 7:58 PM EDT
Ginkgo Bioworks Holdings Stock Forecast
Stock Price Forecast
The 2 analysts that cover Ginkgo Bioworks Holdings stock have a consensus rating of "Hold" and an average price target of $9.50, which forecasts a -14.18% decrease in the stock price over the next year. The lowest target is $9.00 and the highest is $10.
Price Target: $9.50 (-14.18%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Ginkgo Bioworks Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 1 | 1 |
| Total | 7 | 7 | 7 | 7 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Sell Maintains $6 → $9 | Strong Sell | Maintains | $6 → $9 | -18.70% | Aug 25, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $3 → $10 | Strong Buy | Maintains | $3 → $10 | -9.67% | Sep 20, 2024 |
| BTIG | BTIG | Strong Sell Maintains $0.2 → $7 | Strong Sell | Maintains | $0.2 → $7 | -36.77% | Aug 23, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $32 → $12 | Strong Sell | Maintains | $32 → $12 | +8.40% | Jul 9, 2024 |
| BTIG | BTIG | Strong Sell Maintains $20 → $8 | Strong Sell | Maintains | $20 → $8 | -27.73% | Jun 26, 2024 |
Financial Forecast
Revenue This Year
178.85M
from 227.04M
Decreased by -21.23%
Revenue Next Year
204.63M
from 178.85M
Increased by 14.41%
EPS This Year
-5.35
from -10.54
EPS Next Year
-4.81
from -5.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 190.1M | 220.5M | |
| Avg | 178.9M | 204.6M | |
| Low | 171.5M | 191.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -16.3% | 23.3% | |
| Avg | -21.2% | 14.4% | |
| Low | -24.5% | 6.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -5.53 | -4.91 | |
| Avg | -5.35 | -4.81 | |
| Low | -5.22 | -4.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.